Back to search
FDAFDA · Food and drugs·Recall number D-0472-2023

Daytrana (methylphenidate transdermal system) CII, 20mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5554-3.

Published March 29, 2023 · Recall initiated: March 10, 2023

Summary

FDA records drug Class II recall D-0472-2023, published March 29, 2023 and initiated March 10, 2023. Recalling firm: Noven Pharmaceuticals Inc; Status: Ongoing; Reported quantity: N/A; Lot: Lot#: 91957, 92197, Exp. 7/2023; 92476, Exp. 9/2023; 92477, Exp. 10/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Delivery System: Out of specification for shear.

What to do

Voluntary: Firm initiated · Letter

Get an email if DAYTRANA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DAYTRANA
Manufacturer
Noven Pharmaceuticals Inc
Distributor
US Nationwide
Lot
Lot#: 91957, 92197, Exp. 7/2023; 92476, Exp. 9/2023; 92477, Exp. 10/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Daytrana (methylphenidate transdermal system) CII, 20mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5554-3. recalled?

Yes. FDA published recall D-0472-2023 on March 29, 2023. Reported hazard: Defective Delivery System: Out of specification for shear.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DAYTRANA.